Accueil   Diary - News   All news PDC*line Pharma welcomes Dr. Mondher Mahjoubi as chairman of its board of directors

PDC*line Pharma welcomes Dr. Mondher Mahjoubi as chairman of its board of directors

 

 

PDC*line Pharma strengthens its board of directors with an industry leader in the field of immuno-oncology

 

Liège, Belgium and Grenoble, France, June 25, 2020 – PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces that Dr. Mondher Mahjoubi has been named as an independent board member and chairman of the board of directors.

 

 

With more than 25 years of leadership experience and expertise in the biopharmaceutical industry, Dr. Majhoubi will play a critical role in helping guide PDC*line Pharma to become a leader in immuno-oncology vaccines.

 

 

Read the press release